HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Firm Mile High Files CBD Novel Food Applications In EU

Executive Summary

Colorado's Mile High Labs has filed novel food applications with both EFSA and the UK's FSA to ensure it can keep legally supplying its hemp-derived CBD to European customers.

You may also be interested in...



DSM Remodels Nutrition Business With Fundamental Piece – Cannabinoid Ingredients

Royal DSM and Colorado’s Mile High Labs partner to provide companies in supplement, food and beverage sectors with ingredients to develop formulations with CBD and other cannabinoids. They initially are targeting the US and look to enter Canada, South America, Europe and Australia.

UK CBD Firms Given Deadline For EU Compliance

BREAKING NEWS: UK food regulator, FSA, has given CBD firms until the 31 March 2021 to submit valid novel food applications under new EU rules. FSA says it will not take products off shelves until then, but has also warned some consumers against taking CBD due to "potential adverse health effects."

Germany And Sweden Leading The EU In CBD Enforcement Action

Sweden and Germany are cracking down on unauthorized CBD food products and warning their neighbors of the health risks posed to consumers, an analysis by HBW Insight reveals. A large proportion of these CBD products are being sold as food supplements and many originate from the Netherlands. 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS149935

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel